Remove tag research-space
article thumbnail

Grand Rounds October 28, 2022: The HERO (Healthcare Worker Exposure Response & Outcomes) Program: An Online Community to Support Observational Studies, Randomized Trials, and Long-Term Safety Surveillance (Emily O’Brien, PhD, FAHA; Russell Rothman, MD, MPP)

Rethinking Clinical Trials

Duke Clinical Research Institute. On March 21, 2020, in response to the COVID-19 pandemic, PCORI contacted leadership at Duke Clinical Research Institute and PCORnet and a decision was made to focus on the space of healthcare workers. Emily O’Brien, PhD, FAHA. Associate Professor. Duke University School of Medicine.

Trials 130
article thumbnail

Grand Rounds September 22, 2023: Integrating Community Health Workers into Team-Based, Early Childhood Preventative Care (Tumaini Rucker Coker, MD, MBA)

Rethinking Clinical Trials

Based on these findings, the research team initiated a larger PARENT trial that had 3 parent coaches at federally qualified health centers. The research team is in the next phase of local adaptation, having received funding from PCORI for PARENT Adaptation for Black Families: NCH-PCN Partnership.

Trials 271
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Google’s 2021 Title Shakeup Part 2: Our SERP Title Analysis Study

Intouch Solutions

blue links) of the organic results appeared to be pulling from content outside of the HTML title tag at a much higher frequency. URLs Examined: 860 URLs across 50 websites were examined; only URLs with all available data points were part of this research. Specifically, title links (i.e., Our Methodology. Considerations.

article thumbnail

Grand Rounds October 20, 2023: A National Initiative to Eliminate Hepatitis C in the United States – Why This Matters to Clinical Trialists (Rachael L. Fleurence, PhD, MSc; Joshua M. Sharfstein, MD)

Rethinking Clinical Trials

There are possible clinical research components that would include research on treatment during pregnancy, vaccine development, and implementation model research. with the rate of reported acute Hepatitis C cases increasing 400% during 2010-2020. Rates are the highest among 20-39-year-olds.

article thumbnail

Grand Rounds August 19, 2022: Inclusion and Diversity in Clinical Trials: Actionable Steps to Drive Lasting Change (Gerald Bloomfield, MD, MPH; Michelle Kelsey, MD)

Rethinking Clinical Trials

The Duke Clinical Research Institute (DCRI) organized and sponsored a Think Tank to address diversity in clinical trial research. Communities should be involved from the very beginning where both the community and investigators take ownership of the research and are equally involved and interested. Discussion Themes. -Is

article thumbnail

Jolly Good/Teijin Pharma develop VR digital therapeutics for depression

pharmaphorum

Jolly Good is a medical technology company that develops VR solutions and AI-based medical and welfare services that analyse user behaviour in the VR space. It also develops services to support the evolution of medical care and finding purposes in life, in collaboration with various research institutions and companies.

article thumbnail

Rare Disease Spotlight – tracing the rise of orphan drug designations over almost 40 years

Pharmaceutical Technology

Research and drug development for rare diseases has shifted from “niche” to conventional, aided by multiple drivers of growth in the field and favorable legislation. Others judge its success based on the fact that 95% of rare diseases still have no available therapies and patient needs remain unmet.

Drugs 246